Legacy Pharmaceutical Pa.c kaging LLC
FDA inspection history across 2 sites, 2020 to 2022
- 1
- Warning letter
- 1
- Form 483
- 1
- Close-out
Every document, by year
- Warning letter
- Form 483
- Close-out
2020: one Form 483; 2022: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2020–22One Form 483 and one warning letter, at Earth Ci ty, Missouri and Earth City, Missouri.
Cited most
Across all Legacy Pharmaceutical Pa.c kaging observations on file
- 21 CFR 820.90Nonconforming product2
- 21 CFR 820.198Complaint files1
- 21 CFR 820.70Production and process controls1
- 21 CFR 820.75Process validation1
The complete Legacy Pharmaceutical Pa.c kaging file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Earth City, Missouri
One warning letter and one close-out letter · 2022
Latest: Warning letter, Oct 3, 2022 →Earth Ci ty, Missouri
One Form 483 · 2020 · 5 observations
Latest: Form 483, Jan 16, 2020 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-10-03 | Warning letter Warning letter | Earth City, Missouri | — | $99 |
| 2020-01-16 | 483 Form 483 | Earth Ci ty, Missouri | 5 | $99 |
| Undated | Close-out Close-out letter | Earth City, Missouri | — | $99 |
Investigators on these documents
FEI number 3004453700 · most recent document Oct 3, 2022
About Legacy Pharmaceutical Pa.c kaging LLC
How many FDA Form 483s has Legacy Pharmaceutical Pa.c kaging LLC received?
FDA Intel has 1 Form 483 on file for Legacy Pharmaceutical Pa.c kaging LLC; the most recent is dated Jan 16, 2020.
When was Legacy Pharmaceutical Pa.c kaging LLC last inspected by FDA?
The most recent FDA inspection document on file for Legacy Pharmaceutical Pa.c kaging LLC is a Form 483 dated Jan 16, 2020, for the site in Earth Ci ty, Missouri.
What did FDA cite at Legacy Pharmaceutical Pa.c kaging LLC?
The regulations cited most in the observations on file for Legacy Pharmaceutical Pa.c kaging LLC are 21 CFR 820.90 (Nonconforming product), 2 times; 21 CFR 820.198 (Complaint files), 1 time; 21 CFR 820.70 (Production and process controls), 1 time.
Has Legacy Pharmaceutical Pa.c kaging LLC received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Legacy Pharmaceutical Pa.c kaging LLC; the most recent is dated Oct 3, 2022.